Kellogg presents the second annual Kellogg Biotech Case Competition sponsored by Genzyme. The purpose of this competition is to provide students with exposure to real world challenges faced by biotechnology companies in a competitive, learning environment. Additionally, the case competition has been scheduled to coincide with Kellogg's nationally recognized Kellogg Biotech & Healthcare Conference, which students are encouraged to attend.
|When:||Friday, January 13th, 5:00PM CST
|Where:|| Kellogg's Donald P. Jacobs Center, Room To Be Determined
|Awards:||Cash Prizes to First and Second Place.
First Place - $1,500
Second Place - $750
|Schedule:|| 5:00 PM - 5:05 PM Introductions
5:05 PM - 7:05 PM Team Presentations (5 teams approximately 20 minutes each)
7:05 PM - 7:35 PM Final Evaluations By Judges
7:05 PM - 7:35 PM Cocktail Reception (Beer & Wine)
7:35 PM - 8:00 PM Competition De-Brief and Awards Ceremony
|Judges:||Judges to include Genzyme representatives, other industry representatives,
1 member of the Kellogg faculty, and faculty from other top business schools.
|Schedule:||Each team will receive the case 1 week prior to the competition. Each team will develop their case analysis and recommendation(s) in a PowerPoint presentation format that must be submitted by Friday, January 13th at 8:00 AM CST.
|Presentation:||Each team will have 20 minutes to make their presentations including Q&A from the judges.|
About Our Sponsor
One of the world's foremost biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Founded in Boston in 1981, Genzyme has grown from a small start-up to a diversified enterprise with annual revenues exceeding $2 billion and nearly 7,000 employees in locations spanning the globe.
With many established products and services helping patients in more than 80 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences to address a range of unmet medical needs. The company's products and services are focused on rare inherited disorders, kidney disease, orthopedics, transplant and immune disease, cancer, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial research and development program focused on genetic diseases, immune system disorders, heart disease, and cancer.
For more information on Genzyme, please visit www.genyzme.com.